What Amwell and GoodRx’s IPO filings tell us about telehealth finances

What Amwell and GoodRx’s IPO filings tell us about telehealth finances

STAT Plus: What we learned about the business of telemedicine from Amwell and GoodRx’s IPO filings

By REBECCA ROBBINS

ADOBE

STAT examined the IPO filings from Amwell and GoodRx. Here are the key insights they offered about long-murky finances of telemedicine companies.

READ MORE